Accelerating Clinical Trials Through AI-Native Automation
Operation TrialBlazer could help reduce clinical development timelines by 6 to 12 months, but achieving that requires addressing the operational bottlenecks that slow trials down. In this two-part interview with Applied Clinical Trials, Dr. Amber Hill discusses where AI-native automation can reduce administrative friction, particularly in Phase I trials, while keeping human oversight central.